Low risk of nephrogenic systemic fibrosis with group II gadolinium contrast agents in chronic kidney disease
1. In a systematic review and meta-analysis of the use of group II (low risk) gadolinium-based contrast agents (GBCA) for ...
1. In a systematic review and meta-analysis of the use of group II (low risk) gadolinium-based contrast agents (GBCA) for ...
1. Potassium binder therapy with patiromer can promote longer duration of spironolactone use for resistant hypertension in the setting of ...
Fetal nephrogenesis is most significant in the third trimester of pregnancy, and is interrupted by preterm birth before 37 weeks ...
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): ...
Veverimer Versus Placebo in Patients with Metabolic Acidosis Associated with Chronic Kidney Disease: a Multicenter, Randomized, Double-Blind, Controlled, Phase 3 ...
1. Proband exome sequencing revealed that approximately 10% of patients in this study cohort had a detectable genetic variant of ...
1. Patients managed with intensive blood pressure reduction were found to have significantly greater decreases in kidney damage biomarkers compared ...
1. Patients with end-stage renal disease (ESRD) have significantly worse survival outcomes following left ventricular assist device (LVAD) implantation compared ...
1. The kidney failure risk equation (KFRE), currently used in adults to estimate risk for progression to end-stage renal disease ...
1. In a meta-analysis of randomized trials evaluating blood pressure control in patients with stage 3-5 chronic kidney disease (CKD), ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.